drugset / Trial / NCT03132025
Study of Apatinib and Capecitabine Combination to Maintain Treating Metastatic Colorectal Cancer
RandomizedParallel-groupSingle-blindTreatment
Summary
To control apatinib and capecitabine combination to maintain treating metastatic colorectal cancer.
Timeline
- Start
- 2017-04-30
- Primary completion
- 2018-02-28
- Completion
- 2018-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Capecitabine | Small molecule | 1000 mg/m2 | Oral |
| Subject | Rivoceranib | Small molecule | 250 mg | Oral |